Efficacy and safety analysis of BCL-2 inhibitor in relapsed/refractory multiple myeloma with t (11;14) in a single center.
- Author:
Jing Yi BI
1
;
Lei WEN
1
;
Wen Bing DUAN
1
;
Yang LIU
1
;
Sha Sha WANG
1
;
Xiao Jun HUANG
1
;
Jin LU
1
Author Information
- Publication Type:Journal Article
- MeSH: Antineoplastic Agents/therapeutic use*; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone/therapeutic use*; Humans; Multiple Myeloma/drug therapy*; Neoplasm Recurrence, Local/drug therapy*; Proto-Oncogene Proteins c-bcl-2
- From: Chinese Journal of Hematology 2022;43(2):146-149
- CountryChina
- Language:Chinese
